Introduction
============

Prostate cancer is the second most common male malignancy tumor in the world ([@ref-15]). The morbidity and mortality of prostate cancer has surpassed bladder cancer and kidney cancer. It is now the most common tumor in the adult urology department in China ([@ref-49]). There are several factors can increase the risk of prostate cancer (for example, family factors, bald, gonorrhea, smoking; [@ref-44]; [@ref-61]; [@ref-30]), and genetic predisposition is considered to be one of the important factors of the incidence of prostate cancer ([@ref-35]; [@ref-34]; [@ref-24]). At present, 100 susceptibility loci were identified, the mechanism of prostate cancer is incomprehensible, although a large number of studies have been conducted on the development and recurrence of prostate cancer. Prostate-specific antigen (PSA) test has been used to assist the diagnosis of prostate cancer. Early PSA detection, however, could lead to over diagnosis and over treatment of prostate cancer. More recently, advances in high-throughput sequencing and screening techniques have enabled us to screen differently expressed genes at the same time. Therefore, this article aimed to identify the core protein coding genes related to the progression of cancer recurrence, metastasis and prognosis by bioinformatics analysis. As errors in an individual dataset are unavoidable, multiple datasets were analyzed. False positive results could be ignored by independent mRNA microarray analysis; false negative results have been ignored by multiple mRNA microarrays intersection analysis. Thus, four kinds of combinations were established between four datasets downloaded from Gene Expression Omnibus (GEO), differentially expressed genes (DEGs) were identified between cancer and non cancer tissues when the screening criteria met any three of the four datasets ([@ref-41]). Afterwards we obtained six core differential expression genes which were verified in TCGA PRAD, [GSE21032](GSE21032) and other datasets, besides these six core genes acted as independent prognostic factors and positively correlated with Gleason score ([@ref-37]). The six real core genes were thereby identified as potential biomarkers for prostate cancer.

Materials and Methods
=====================

Microarray data
---------------

Five prostate cancer microarray datasets were obtained from NCBI GEO (<https://www.ncbi.nlm.nih.gov/geo/>) ([@ref-14]): [GSE104749](GSE104749) ([@ref-65]), [GSE38241](GSE38241) ([@ref-4]), [GSE69223](GSE69223) ([@ref-50]) and [GSE46602](GSE46602) ([@ref-53]), [GSE21032](GSE21032) ([@ref-70]). The platform for [GSE104749](GSE104749) was GPL570 Affymetrix Human Genome U133 Plus 2.0 Array which contained 4 PCa excision tissue and 4 noncancerous excision tissue samples. The platform for [GSE38241](GSE38241) was GPL4133 Agilent-014850 Whole Human Genome microarray 4 × 44 K G4112F (Feature Number version) which contained 21 PCa excision tissue and 18 noncancerous excision tissue samples. The platform for [GSE69223](GSE69223) was GPL 570 Affymetrix Human Genome U133 Plus 2.0 Array which contained 15 PCa excision tissue samples and 15 noncancerous excision tissue samples. The platform for [GSE46602](GSE46602) was GPL570 Affymetrix Human Genome U133 Plus 2.0 Array which contained 36 excision tissue and 14 noncancerous tissue samples. The platform for [GSE21032](GSE21032) was GPL5188 which contained 150 prostate excision tissue samples and 29 normal adjacent benign prostate excision tissue samples. Meanwhile we also downloaded clinical information and gene matrix from TCGA database (<https://genome-cancer.ucsc.edu/>) ([@ref-9]) which contained 52 normal prostate tissue samples and 495 prostate cancer samples.

Identification of DEGs
----------------------

The GEO2R (<http://www.ncbi.nlm.nih.gov/geo/geo2r>) was used to screen DEGs between prostate carcinoma samples and noncancerous samples [GSE104749](GSE104749), [GSE38241](GSE38241), [GSE69223](GSE69223), [GSE46602](GSE46602) datasets. GEO2R is a tool which allows users to obtain DEGs by comparing different groups. The DEGs are screened and sorted by significance. The genes with \|log2FC\| (fold change) ≥ 1 and *P*-value \< 0.01 were considered to be DEGs.

GO and pathway enrichment analysis
----------------------------------

The Database for Annotation, Visualization and Integrated Discovery (DAVID, v6.8) is a function enrichment tool which supplies biological explanations of gene lists and proteomic studies from high-throughput sequencing ([@ref-29]). Higher-order functions of cells and organisms were derived from KEGG (<http://www.genome.ad.jp/kegg/>) databases ([@ref-36]). The biological process, molecular function and cellular component were analyzed in GO (<http://www.geneontology.org>) ([@ref-5]). A *P* value of \< 0.05 was the criterion for significance.

Conduction of protein--protein interaction network
--------------------------------------------------

The direct and indirect interactions between proteins were established by STRING database (<http://string-db.org/>) ([@ref-16]). The PPI network was analyzed by STRING database with a criterion of combined score \>0.4 considered to be a significant result. The biological network visualization of the protein interactions was revealed by the open source software Cytoscape 3.7.1 ([@ref-66]). The MCODE in Cytoscape was used to the 20 core genes and significant module ([@ref-7]). Afterwards the PPI network and the significant module were established with the criteria (MCODE scores \> 5, degree cutoff = 2, node score cutoff = 0.2, Max depth = 100 and *k*-score = 2).

Hub genes selection and prognosis analysis
------------------------------------------

The candidate core genes were identified with degrees ≥20 of the most significant model in PPI network. The co-expression network of the candidate genes was established by the online platform cBioPortal (<http://www.cbioportal.org>) ([@ref-17]). The phenotype analysis of the core genes was performed by a heat map that was conducted by UCSC (<http://genome-cancer.ucsc.edu>) ([@ref-23]). Afterwards, to further screen out the independent prognosis factors of prostate cancer, [GSE21032](GSE21032) log2 mRNA expression data and the clinical information were download from cBioPortal (<http://cbio.mskcc.org/cancergenomics/prostate/data>) and (<https://www.cbioportal.org/study/clinicalData?id=prad_mskcc>). We analyzed the correlation between candidate key genes and phenotype in the [GSE21032](GSE21032) data performed by box plots, KM curve and ROC curve, *P* value \< 0.05 was the criterion for significance. In this way, we identified the real core genes and verified their important value in the large sample TCGA.

External data set evaluation and verification
---------------------------------------------

The core protein coding genes were identified, the prognosis and clinical value were illustrated in the above study. Furtherly, the interaction between the core genes and metastasis state were analyzed by Oncomine (<http://www.oncomine.com>) ([@ref-72]; [@ref-21]; [@ref-73]). The Human Protein Atlas (HPA) (<http://www.proteinatlas.org/>) is an open source database to explore the human proteome. HPA combines various omics techniques to map all human proteins in cells, tissues and organs and the expression of core genes were evaluated on transcriptional and translational level. The analysis of variance was applied to show the correlativity between the expression of core genes and clinical stage to reveal the expression difference among different stages, the clinical data was from TCGA clinical information.

Gene set enrichment analysis
----------------------------

In set TCGA, samples were divided into two groups based on the expression of core genes. To predict the function and effect of core genes, gene set enrichment (GSEA) (<http://software.broadinstitute.org/gsea/index.jsp>) ([@ref-67]) was applied to identified the gene set that expressed relatively with our core genes, and analyzed the pathway the gene set involved in. Pathway with *P* \< 0.05 was considered to be significance. Afterwards, we identified the most significance pathway by taking the intersection of core genes. The results were performed by "ggplot2" packages ([@ref-31]) in R 3.6.2.

Result
======

Identification of DEGs in PCa
-----------------------------

A total of 298 downregulated genes and 137 upregulated DEGs were screened, as shown in the Venn diagram ([Fig. 1A](#fig-1){ref-type="fig"}). Expression datasets [GSE46602](GSE46602), [GSE104749](GSE104749), [GSE38241](GSE38241) and [GSE69223](GSE69223) were obtained from the GEO database. GEO2R was used to screen the DEGs with the criteria of \|log2FC\| (fold change) ≥ 1 and *P*-value \< 0.01. Afterward, we got 1,953 DEGs in [GSE46602](GSE46602), 2,513 DEGs in [GSE104749](GSE104749), 2,682 DEGs in [GSE38241](GSE38241) and 2,639 DEGs in [GSE69223](GSE69223). Considering the errors between the four datasets, we used the genes that met the screening criteria of any three datasets for the next analysis.

![(A) DEGs Venn diagram of four prostate cancer microarray data. (B) PPI network for DEGs. (C) The most significant module of DEGs.\
(A) DEGs Venn diagram of [GSE38241](GSE38241), [GSE69223](GSE69223), [GSE104749](GSE104749), [GSE46602](GSE46602). As a result, 298 downregulated genes and 137 upregulated DEGs were screened, as shown in the Venn diagram. (B) The protein and protein interactions (PPI) 340 DEGs in 435 DEGs were performed in protein network and 167 DEGs were shown with degree \>7. The upregulated genes were marked with orange,and the downregulated gene were marked with blue. (C) The most statistically significant module was acquired using Cytoscape.](peerj-08-8786-g001){#fig-1}

TCGA prostate cancer gene matrix was transformed by log2(exp + 1).

KEGG and GO enrichment analyses of DEGs
---------------------------------------

DAVID was used to analyze the function classification of the 298 downregulated genes and 137 upregulated DEGs obtained by intersection. Gene Ontology results showed DEGs were significantly enriched in cell and biological adhesion, mesenchymal cell differentiation and the development of biological process. For the cellular component groups, the extracellular region and the matrix were significantly enriched. In the group analyzed for molecular function, the glutathione transferase activity, extracellular matrix structural constituent identical protein binding, and general identical protein binding were significantly enriched. KEGG pathway analysis revealed that the DEGs were mainly enriched in focal adhesion and in the glutathione metabolism pathway ([Table 1](#table-1){ref-type="table"}).

10.7717/peerj.8786/table-1

###### GO and KEGG pathway enrichment analysis of DEGs in prostate cancer samples.

KEGG pathway analysis revealed that the DEGs were mainly enriched in focal adhesion and Glutathione metabolism pathway.

![](peerj-08-8786-g008)

  Pathway ID     Term                                          Count   *P*-value
  -------------- --------------------------------------------- ------- -----------
  <GO:0007155>   Cell adhesion                                 39      1.86E−06
  <GO:0007155>   Biological adhesion                           39      1.88E−06
  <GO:0048762>   Mesenchymal cell differentiation              9       2.52E−05
  <GO:0014031>   Mesenchymal cell development                  9       2.52E−05
  <GO:0044421>   Extracellular region part                     63      3.08E−14
  <GO:0031012>   Extracellular matrix                          32      6.05E−11
  <GO:0005578>   Proteinaceous extracellular matrix            29      9.94E−10
  <GO:0005578>   Extracellular region                          87      1.37E−09
  <GO:0004364>   Glutathione transferase activity              6       7.31E−05
  <GO:0005201>   Extracellular matrix structural constituent   10      1.57E−04
  hsa04510       Focal adhesion                                17      4.85E−05
  hsa04510       Drug metabolism                               9       1.64E−04
  hsa04510       Glutathione metabolism                        8       2.54E−04

**Note:**

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes.

PPI and module analysis
-----------------------

We acquired the PPI network and identified the most significant model based on the 298 downregulated genes and 137 upregulated DEGs. Cytoscape software and the online database STRING (available online: <https://string-db.org/>) were used to screen core genes. 340 DEGs in 435 DEGs were performed in protein network and 167 DEGs were shown with degree \>7 ([Fig. 1B](#fig-1){ref-type="fig"}). The most statistically significant module was acquired using Cytoscape ([Fig. 1C](#fig-1){ref-type="fig"}). The KEGG and GO enrichment of this module were analyzed using DAVID. Results showed that the genes in the most significant module were mainly enriched in the functions of cell cycle phases, mitosis, cell division, the microtubule cytoskeleton, the p53 signaling pathway and Oocyte meiosis ([Table 2](#table-2){ref-type="table"}).

10.7717/peerj.8786/table-2

###### GO and KEGG pathway enrichment analysis of DEGs in the most significant module.

The genes in the most significant module were mainly enriched in the function of cell cycle phase, mitosis, cell division, microtubule cytoskeleton, spindle, p53 signaling pathway, Oocyte meiosis.

![](peerj-08-8786-g009)

  Pathway ID     Term                       Count   *P*-value
  -------------- -------------------------- ------- -------------
  <GO:0000279>   M phase                    14      6.27E−18
  <GO:0022403>   Cell cycle phase           14      1.27E−16
  <GO:0007067>   Mitosis                    11      4.12E−14
  <GO:0000280>   Nuclear division           11      4.12E−14
  <GO:0051301>   Cell division              10      4.04E−11
  <GO:0015630>   Microtubule cytoskeleton   9       1.90E−07
  <GO:0005819>   Spindle                    6       1.04E−06
  <GO:0051276>   Chromosome organization    8       1.65E−06
  <GO:0044430>   Cytoskeletal part          9       1.22E−05
  <GO:0003682>   Chromatin binding          4       6.21E−04
  hsa04115       p53 Signaling pathway      3       0.003543755
  hsa04114       Oocyte meiosis             3       0.009071242

**Note:**

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes.

Candidate gene selection, analysis
----------------------------------

A total of 20 core genes with a degree ≥20 selected by MCODE were obtained from the protein--protein network, and they were considered to be candidate core genes. The co-expression network of core genes was analyzed by cBioPortal ([Fig. 2A](#fig-2){ref-type="fig"}). Heatmap showed that the core genes in cancer groups upregulated more significantly than in normal groups by UCSC (<https://xena.ucsc.edu>) ([Fig. 2C](#fig-2){ref-type="fig"}). In addition, the core genes were considered to have a close relation to the Gleason score ([Fig. 2B](#fig-2){ref-type="fig"}). We adjusted the highest color according to 100% saturation parameters of log2 (norm_count + 1) ≥ 10.4 and the lowest color according to 100% saturation parameters of log2 (norm_count + 1) ≤ 2.65 ([Fig. 2B](#fig-2){ref-type="fig"}). We compared solid normal tissue to primary tumor tissue ([Figs. 2B](#fig-2){ref-type="fig"} and [2C](#fig-2){ref-type="fig"}). We found that CCNB1, TPX2, CENPF, TOP2A, MKI67, ECT2, TK1, RRM2, NUSAP1, CKS2 were overexpressed consistently in the 568 TCGA Prostate Cancer (PRAD) samples. Therefore, these genes were closely related to carcinogenesis and stage.

![(A) The interaction network between the hub genes and their co-expression genes. (B and C) Heat map of hub genes by UCSC.\
(A) The interaction network between the hub genes and their co-expression genes by cBioPortal. Nodes with a black outline represent hub genes. Nodes with thin black genes represent co-expression genes. (B) The color parameters of C were adjusted as max color 100% saturation of log2(norm_count + 1) = 10.4; min color 100% saturation of log2(norm_count + 1) = 2.65. (C) Heat map of hub genes by UCSC. The samples of pink are normal tissue. The cancer samples are blue. High expressed genes were marked yellow. The low expressed genes were blue.](peerj-08-8786-g002){#fig-2}

Selection real core genes
-------------------------

To further explore the relationship to phenotype and prognosis status, we performed differential analysis, disease-free survival analysis and ROC curve analysis in [GSE21032](GSE21032) ([Figs. 3A](#fig-3){ref-type="fig"}--[3R](#fig-3){ref-type="fig"}). CCNB1, CKS2, RRM2, MKI67, TK1 and TOP2A were considered to be core genes with the lowest *P* value in the above 20 candidate genes. The results showed that MKI67 had the best prognostic value and the most significant *P* value (*P* = 0.0024). In addition, CCNB1, CKS2, RRM2, TK1 and TOP2A also showed closely clinical correlation. Based on the above analysis, the six genes were predicted to be the core factors affecting prostate cancer. To determine our prediction, we found CCNB1, CKS2, MKI67, RRM2, TK1 and TOP2A acted as independent prognostic factors in TCGA prostate cancer ([Figs. 4A](#fig-4){ref-type="fig"}--[4R](#fig-4){ref-type="fig"}). In order to verify the differential expression of key factors at the transcriptional and translational levels, we found cases of immunohistochemistry of core factors in the HPA database. In contrast to normal prostate tissue, we found that the cancer group stained deeper. At the same time, the expression difference of core genes was found between local lesions and metastatic patients in different external data sets of Oncomine database ([Figs. 5A](#fig-5){ref-type="fig"}--[5L](#fig-5){ref-type="fig"}). These findings clarified that core factors played an important role in the entire process of prostate cancer.

![Differential analysis, disease-free survival analysis and ROC curve analysis in [GSE21032](GSE21032).\
(A--F) The box plots of CCNB1, CKS2, MKI67, RRM2, TK1, TOP2A from [GSE21032](GSE21032). The six core genes were found to be risk factors in [GSE21032](GSE21032). (G--L) The disease-free survival KM curve of the six core genes were analysis by [GSE21032](GSE21032), which showed prognosis value of prostate cancer patients. The Log-rank *P* value \< 0.05 was considered to be significance. We recommended CKS2 as prognosis factors because the survival difference in 5 years is significance. (M--R) The ROC curve and AUC of the six core genes were showed.](peerj-08-8786-g003){#fig-3}

![Differential analysis, disease-free survival analysis and ROC curve analysis in TCGA.\
(A--F) The box plots of CCNB1, CKS2, MKI67, RRM2, TK1, TOP2A from TCGA. The six core genes were identified to be risk factors in TCGA. (G--L) The disease-free survival KM curve of the six core genes were analysis by TCGA, which demonstrated prognosis value of prostate cancer patients. The Log-rank *P* value \< 0.05 was considered to be significance. (M--R) The ROC curve and AUC of the six core genes were showed.](peerj-08-8786-g004){#fig-4}

![The gene expression of CCNB1, CKS2, MKI67, RRM2, TK1, TOP2A on transcriptional and translational level.\
Verification of the expression of core genes on transcriptional and translational level by Oncomine database and The Human Protein Atlas database (immunohistochemistry) CCNB1 (A and G), CKS2 (B and H), MKI67 (C and I), RRM2 (D and J), TK1 (E and K), TOP2A (F and L).](peerj-08-8786-g005){#fig-5}

Clinical relevance and GSEA
---------------------------

CCNB1, CKS2, MKI67, RRM2, TK1 and TOP2A were found with positive clinical correlation to GLEASON SCORE ([Figs. 6A](#fig-6){ref-type="fig"}--[6F](#fig-6){ref-type="fig"}), and we could clearly identify the core factors as cancer risk factors, the expression level increased as Gleason score elevated. GSEA analysis suggested that cell cycle, DNA replication, GNRH signaling pathway, P53_signaling_pathway, were enriched in CKS2, MKI67, RRM2, TK1 and TOP2A high expression group jointly ([Figs. 7A](#fig-7){ref-type="fig"}--[7E](#fig-7){ref-type="fig"}). The *P*-value of core genes were listed ([Table 3](#table-3){ref-type="table"}). Therefore, the core genes were positively related to the four cancer related pathways jointly.

![The gene expression of CCNB1, CKS2, MKI67, RRM2, TK1, TOP2A as represented by different Gleason scores.\
The gene expression of (A) CCNB1, (B) CKS2, (C) MKI67, (D) RRM2, (E) TK1, (F) TOP2A as represented by different Gleason scores. The results were evaluated by variance analysis.](peerj-08-8786-g006){#fig-6}

![GSEA pathway enrichment analysis.\
GSEA pathway enrichment analysis of high expression groups of (A) CKS2, (B) MKI67, (C) RRM2, (D) TK1, (E) TOP2A. Pathway with FDR \< 0.05 were considered to be significance.](peerj-08-8786-g007){#fig-7}
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###### GSEA results of core genes in TCGA PRAD.

The *P*-value of the P53_signaling_pathway, GNRH signaling pathway, DNA replication, cell cycle in the 5 core genes were listed.

![](peerj-08-8786-g010)

          P53_signaling_pathway   GNRH_signaling_pathway   DNA_replication   Cell_cycle                                  
  ------- ----------------------- ------------------------ ----------------- ------------ --------- ---------- --------- -------------
  RRM2    \<0.001                 0.0012                   \<0.001           4.65E−04     \<0.001   0.001      \<0.001   6.04E−04
  CKS2    \<0.001                 0.0054                   0.125             0.1249       \<0.001   0.0059     \<0.001   0.00254688
  MKI67   \<0.001                 0.0026                   \<0.001           9.34E−04     \<0.001   0.0023     \<0.001   0.001120284
  TK1     \<0.001                 0.0124                   0.0653            0.0708       \<0.001   0.0049     \<0.001   0.003169282
  TOP2A   0.001992032             0.0045                   \<0.001           0.0029       \<0.001   0.004227   \<0.001   0.00279397

Discussion
==========

Despite the advances that have been made in understanding the molecular processes at the onset and in the progression of this disease, PCa still remains high morbidity and mortality, particularly in low-income countries ([@ref-25]). However, the formation mechanisms of PCa are incomprehensive. Therefore, we excavated potential biomarkers for diagnosis and treatment ([@ref-77]).

In the present study, 298 downregulated and 137 upregulated genes mainly enriched in cell adhesion, biological adhesion, regulation of cell proliferation and oxidation reduction. Epithelial cell adhesion molecule (Ep-CAM) is considered to have a critical role in carcinogenesis and cell proliferation ([@ref-68]). In addition, oxidoreductase activity often plays a crucial role in antioxidant defense and encodes tumor suppressors that are active in tumorigenesis ([@ref-41]). Moreover, in the prostate carcinoma PC-3 cell model, the action of the gastrin releasing peptide (GRP) analog, bombesin (BN), on the activation of focal adhesion kinase (FAK) and its invasiveness suggests that this kinase might favor metastasis ([@ref-39]). In conclusion, these biological functions are closely related to the development and progression of prostate cancer.

Afterwards, a total of 20 candidate core genes were screened with degree ≥20. The full name and the function of the 20 core genes are listed ([Table 4](#table-4){ref-type="table"}). CCNB1, CKS2, MKI67, RRM2, TK1, TOP2A were identified as real core genes by [GSE21032](GSE21032) and validated in TCGA. The overexpression of CKS2 corresponds to metastasis and prognosis in various malignancies such as breast cancer, liver cancer and PCa ([@ref-51]). Other research showed that the forced expression of CKS2 has a positive correlation to cell growth, and also protects the cells from apoptosis ([@ref-40]). Thymidine kinase 1 (TK1) participates in DNA precursor synthesis and acts as a biomarker for malignant cancer including prostate and breast cancer ([@ref-32]). Meanwhile, research into serological TK1's use in predicting precancer in a study involving 56,178 people showed that serological TK1 protein is a potential proliferative biomarker for early discovery of persons at risk for the development of, or who already have, malignancies or diseases associated with the development of malignancies ([@ref-74]). Moreover, TK1 is upregulated in the S phase of the cell cycle and its presence in cells is an indicator of active cell proliferation ([@ref-33]). The marker of proliferation, Ki-67 (MKI67), functions to mark tumor cell proliferation, including in the prostate, and has a close relation to the epithelial-mesenchymal transition (EMT) ([@ref-45]). Ki67 may improve the prediction of prostate cancer outcomes based on pathological standard parameters, improving prognosis as well as the monitoring of prostate cancer patients ([@ref-58]). TOP2A is considered to be a biomarker for early identification of patients who have increased metastatic potential ([@ref-38]). TOP2A encodes for topoisomerase IIα which controls the topology structure of DNA as well as cell cycle progression. This enzyme is a cell proliferation biomarker of cancer and normal tissue that is valuable for prostate cancer treatment ([@ref-13]; [@ref-42]). Cyclin B1 binds to CDC2 to ensure the transition toward mitosis by acting in the cell cycle from the G2 to M phase. High cyclin B1 levels, meanwhile, contribute to the development of polyploidy. Recent research has shown that Cyclin B1 is involved in breast, prostate cancer ([@ref-55]; [@ref-63]). A study also showed that elevated Cyclin B1 levels served as a biomarker for the prognosis of prostate cancer patients who were being treated with chemotherapy ([@ref-18]). Ribonucleotide reductase regulatory subunit M2 (RRM2) is an enzyme that limits the rate of DNA synthesis and repair ([@ref-43]; [@ref-76]). Mostly, RRM2 was overexpressed in PCa patients with a high Gleason score and an advanced T stage. RRM2 was considered to be a biomarker for prediction of recurrence in low risk PCa patients ([@ref-28]). In this study, these genes were confirmed to be the core genes in the same protein--protein network. The expression level performed consistently in prostate cancer. By the analysis of GSEA we found that these genes induced prostate cancer consistently by the cell cycle pathway and P53 signaling pathway and GNRH signaling pathway.

10.7717/peerj.8786/table-4

###### Functional roles of 20 core genes with degree ≥20.

These biological functions are closely related to the prostate cancer. A total of 20 core genes were screened with degree ≥20. The full name and the function of the 20 core genes were listed.

![](peerj-08-8786-g011)

  No.   Gene symbol   Full name                                              Function
  ----- ------------- ------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------
  1     CKS2          Cyclin kinase subunit 2                                Overexpressed CKS2 promotes cell growth and protects cell from apoptosis
  2     TK1           Thymidine kinase 1                                     TK1 is related to DNA precursor synthesis, acts as a proliferating biomarker of prostate and breast cancer
  3     MKI67         Marker of proliferation Ki-67                          KI-67 is a marker of tumor cell proliferation and the epithelial-mesenchymal transition
  4     TOP2A         Topoisomerase IIα                                      TOP2A controls the topology structure of DNA and cell cycle progression
  5     CCNB1         Cyclin B1                                              A high cyclin B1 level contributes to the development of polyploidy and was a prognosis biomarker of prostate cancer for chemotherapy
  6     RRM2          Ribonucleotide-reductase regulatory subunit M2         RRM2 limits the rate of DNA synthesis and repair. It was considered to be a biomarker to predict recurrence in PCa patients with low-risk
  7     EZH2          Enhancer of Zeste homolog 2                            Drug targeting therapy EZH2 may be a new therapeutic strategy for advanced PCa and docetaxel-resistant PCa patients
  8     AURKA         Aurora kinase A                                        AURKA was considered to be a potential prognostic biomarker for the progression of high-risk small-cell prostate cancer
  9     BIRC5         Baculoviral IAP Repeat containing 5                    BIRC5 may prevent apoptotic cell death, by survivin, a protein that inhibits apoptosis
  10    CCNB2         Cyclin B2                                              CDC2 specifically binds to Cyclin B2 to increase cell migration which is related to the development of CRPC
  11    CDCA8         Cell division cycle associated 8                       Overexpressed CDCA8 is related to mitosis and cell growth and acts as a prognosis biomarker of breast cancer
  12    TPX2          Targeting protein for Xenopus kinesin-like protein 2   TPX2 is a microtubule-associated protein linked to mitosis and spindle assembly and targeting TPX2 is a strategy of PCa
  13    CENPF         Centromere protein F                                   CENPF acts in the centromere-kinetochore complex and chromosomal segregation, it is related to aggressive prostate cancer
  14    NVAPG         Non-SMC condensin I complex subunit G                  NCAPG acts as a target of miR-99a-3p in PCa cells, overexpression of NCAPG is related to CRPC
  15    NUSAP1        Nucleolar and spindle-associated protein 1             NUSAP1 is a prognosis biomarker in the early stage of PCa patients
  16    ANLN          Anillin actin binding protein                          ANLN was found to be related to cell cycle and growth of PCa cells
  17    CDCA5         Cell division cycle associated 5                       Knockdown CDCA5 may cause cell cycle arrest in the G2/M phase
  18    ECT2          Epithelial cell transforming sequence 2                ECT2 is a guanine nucleotide exchange factor that is related to the progression of tumors
  19    HMMR          Hyaluronan-mediated motility receptor                  Hyaluronan-mediated motility receptor (HMMR) binds native and fragmented HA, promotes HA uptake
  20    CENPU         Centromere protein U                                   CENPU upregulation can increase the invasiveness of prostate cancer

Besides the six core genes we mentioned, we found EZH2, AURKA, BIRC5, CCNB2, TPX2, CENPF, NCAPG, NUSAP1 involved in the 20 candidate genes were demonstrated to be risk factors of prostate cancer. Zeste homolog 2 (EZH2) acts as the methyltransferase component of PRC2. Its enhancer regulation disorder is widely found in many aggressive, advanced cancers ([@ref-54]). PRC2 inhibits stem cell self-renewal, cell cycle, cell differentiation and cell transformation through EZH2 (H3K27me3) modification ([@ref-2]). Drug therapies targeting EZH2 may be a new strategy for advanced PCa and docetaxel-resistant PCa patients ([@ref-46]; [@ref-60]). Aurora kinase A is encoded by the AURKA gene and has a vital function in the development of the cell cycle. It both controls and promotes entry into mitosis ([@ref-47]). Studies have shown that AURKA is linked to pathological stage and distant metastasis in HCC ([@ref-10]). The AURKA gene has been proven to amplify in 67% of PCa patients with highly aggressive hormone-naive castration resistant cancer. AURKA, therefore, was considered to be a potential prognostic biomarker for the progression of high-risk small-cell prostate cancer's resistance to castration ([@ref-57]). One aspect of cancer is that apoptosis is uninhibited. Survivin, an inhibitor-of-apoptosis protein, is encoded by BIRC5, a gene that is linked to the regulation of apoptosis and cell division ([@ref-52]; [@ref-26]). Studies have shown that BIRC5 is a biomarker for Oral Squamous Cell Carcinoma as well as breast, liver and prostate cancer. In PTEN deletion mouse model, there was a positive correlation between the survivin level and tumor growth. Researchers found that survivin plays an important role in the conversion process of prostatic intraepithelial neoplasia to adenocarcinoma ([@ref-1]) CCNB2 is linked to the process of transition from the G2 to the M phase. It has acted as a prognosis biomarker of non-small-cell lung cancer ([@ref-59]). Recently, studies have shown that CDC2 specifically binds to Cyclin B2 to increase cell migration, relating to development in CRPC ([@ref-27]; [@ref-48]). The targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a microtubule associated protein that targets TPX2 repressed breast cancer by inhibiting the PI3k/AKT/P21 signaling pathway and activating the p53 pathway ([@ref-11]). High levels of chromosome missegregation is related to cell death and tumorigenesis. Recently, studies have shown that targeting TPX2 in breast and prostate cancer lowered the rate of chromosome missegregation, and have therefore regarded TPX2 as a candidate biomarker for treatment ([@ref-56]). Thus, TPX2 is considered to be a candidate target for PCa patients. Centromere protein F participates in cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling ([@ref-64]). Recent work suggests that the upregulation of CENPF is linked to aggressive prostate cancer ([@ref-22]). NCAPG has been demonstrated to be related to the overexpression of CCNB1. It is suggested to be a candidate target for HCC treatment ([@ref-78]). The overexpression of Non-SMC condensing I complex subunit G (NCAPG) is involved in CRPC, and thus it may be a biomarker for PCa ([@ref-3]). Nucleolar and spindle-associated protein 1 (NUSAP1) is a prognosis biomarker in the in the earliest stage of PCa ([@ref-20]). The overexpression of NUSAP1 may be related to the increased invasion and proliferation of PCa cells through the loss of RB1 ([@ref-19]).

Afterwards, we found the researches of CDCA8, ANLN, CDCA5, ECT2, HMMR, CENPU were poor, which the prognosis value and mechanisms needed further investigation. Cell division cycle associated 8 (CDCA8) over-expression is related to mitosis and tumor growth and may act as a prognosis biomarker in bladder cancer, cutaneous melanoma, breast cancer and osteosarcoma ([@ref-8]; [@ref-12]). The regulation mechanism of CDCA8 in PCa patients, however, is unclear and needed further study. ANLN was found to relate to the cell cycle and growth in PCa, but the regulation mechanisms are currently unknown ([@ref-69]). CDCA5 knockdown led to cell cycle arrest in the G2/M phase ([@ref-71]). Epithelial cell transforming sequence 2 (ECT2) acts as an exchange factor of the guanine nucleotide, which is related to the progression of cell division regulation and the cell cycle ([@ref-6]). Hyaluronan-mediated motility receptor (HMMR) promotes HA uptake, and related time to biochemical failure in Gleason score 7 tumor ([@ref-62]). Overexpression of CENPU is related to breast cancer, lung cancer, ovarian cancer and prostate cancer. Upregulated CENPU can increase the invasiveness of PCa cells ([@ref-75]).

In this study, we identified CKS2, TK1, MKI67, TOP2A, CCNB1 and RRM2 as crucial components in the diagnosis and treatment of PCa. They acted together in the same pathway to induce prostate cancer. The research of the correlation between molecules in cell cycle, DNA replication, GNRH signaling pathway, P53_signaling pathway could reveal the underlying causes of cancer and provide novel ideas for research into target drugs. Meanwhile, the expression difference of CDCA8, ANLN, CDCA5, ECT2, HMMR and CENPU were significantly which needed in-deep study.

Conclusion
==========

This study excavated the core genes of prostate cancer, analyzed their functions, pathways, and their phenotype by means of reliable bioinformatics analysis of multiple datasets. The core genes in this study were considered to be potential targets and biomarkers, providing new ideas for the diagnosis and treatment of prostate cancer. More experimental studies are needed, however, to verify the mechanisms of these genes in prostate cancer.
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